PhRMA pushes back as prescription drug spending continues to rise, according to STAT+ newsletter
STAT+ Health Care Inc. newsletter author Bob Herman reports on the growing concern that prescription drug spending is rising despite industry attempts to downplay it. The piece appears in the July 27, 2026 edition of the STAT+ weekly email.
The article highlights that PhRMA, the main pharmaceutical lobbying group, is urging the public and policymakers to ignore the clear increase in drug costs. It suggests the lobby’s messaging aims to deflect attention from the spending trend.
The newsletter excerpt notes the author’s focus on health-care finance, offers a way to contact him, and reminds readers that full access requires a subscription.
This writeup was produced by pharmadog from original reporting by STAT.
Original headline: “STAT+: Pharma’s drug spending deflection”
read at STAT ↗
comments(0)
5-min edit window · permanent after that